Safety and Pharmacokinetics Study of Human Monoclonal Antibody (FGI-101-1A6)
Status:
Unknown status
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of the anti-TSG101
human monoclonal antibody (FGI-101-1A6)when administered intravenously to healthy volunteers.